Cetrorelix Acetate Kit
Product Images NDC 68083-600

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Cetrorelix Acetate (NDC 68083-600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cetro-spl-structure (Cetro Spl Structure)

Chemical structure of cetrorelix acetate showing its detailed molecular configuration including peptide bonds and functional groups, with acetic acid (AcOH) indicated.*

FDA Label Image

Cetro-spl-fig-1 (Cetro Spl Fig 1)

An instructional illustration showing hand washing technique, depicting water droplets falling onto hands as they are rubbed together under running water.*

FDA Label Image

Cetro-spl-fig-2 (Cetro Spl Fig 2)

cetrorelix acetate kit shown, including a vial of injectable solution, a sterile syringe, a needle, and an alcohol swab. The vial label indicates the product name cetrorelix acetate and the packaging suggests it is for prescription use. The kit components are arranged on a white background, with branding and detailed text visible on the vial label.*

FDA Label Image

Cetro-spl-fig-3 (Cetro Spl Fig 3)

An instructional illustration showing how to open a vial. The first frame depicts gripping and twisting the vial cap, and the second frame shows peeling off the cap to remove it from the vial. The vial is likely part of a cetrorelix acetate kit by Gland Pharma Limited.*

FDA Label Image

Cetro-spl-fig-4 (Cetro Spl Fig 4)

An instructional illustration showing a syringe and its needle cap being removed by lifting the cap upwards. The image demonstrates the preparation step for administering cetrorelix acetate, KIT by Gland Pharma Limited.*

FDA Label Image

Cetro-spl-fig-5 (Cetro Spl Fig 5)

Instructional diagram depicting the proper method to draw medication from a vial into a syringe. The image shows a syringe with a needle inserted into a vial, with an arrow indicating the direction or action to be taken.*

FDA Label Image

Cetro-spl-fig-6 (Cetro Spl Fig 6)

An illustration showing hands preparing an injection, where one hand holds a vial and the other hand uses a syringe to draw liquid from it. The image focuses on the technique of vial and syringe handling.*

FDA Label Image

Cetro-spl-fig-7 (Cetro Spl Fig 7)

An instructional illustration showing the assembly of a syringe with a vial. The image depicts a vial positioned above a syringe with an arrow pointing downward, indicating the syringe being inserted into the vial.*

FDA Label Image

Cetro-spl-fig-8 (Cetro Spl Fig 8)

An instructional diagram illustrating how to assemble a syringe and needle, showing attachment of the needle to the syringe by aligning and twisting motions represented with arrows.*

FDA Label Image

Cetro-spl-fig-9 (Cetro Spl Fig 9)

An instructional illustration showing a syringe with a needle cap being removed, indicated by an arrow pointing away from the needle, likely demonstrating preparation steps for administration of cetrorelix acetate kit by Gland Pharma Limited.*

FDA Label Image

Cetro-spl-fig-10 (Cetro Spl Fig 10)

Illustrative diagram showing two steps: first, a person pointing to an injection site on their abdomen; second, hands holding and preparing a syringe for injection. The image appears to instruct on administering a subcutaneous injection, likely related to the use of cetrorelix acetate kit.*

FDA Label Image

Cetro-spl-fig-11 (Cetro Spl Fig 11)

An instructional illustration showing a hand holding a syringe above a container labeled 'BIOHAZARD,' indicating proper disposal of medical sharps in a biohazard waste container.*

FDA Label Image

Cetro-spl-principle-carton (Cetro Spl Principle Carton)

Cetrolix Acetate for Injection 0.25 mg/vial kit by Gland Pharma Limited. The carton includes one single-dose vial with lyophilized powder for reconstitution, one pre-filled syringe with diluent, one 20-gauge needle, and one 27-gauge needle. The label states storage instructions and indicates it is for subcutaneous use only.*

FDA Label Image

Cetro-spl-tray-label (Cetro Spl Tray Label)

Label for cetrorelix acetate for injection 0.25 mg vial kit. The label states the kit contains one single-dose vial with lyophilized powder for reconstitution, one pre-filled syringe with diluent, one 20-gauge needle, and one 27-gauge needle. Storage instructions specify refrigeration at 2-8°C (36-46°F). The label includes subcutaneous use and sterile use notes, manufacturer details for Gland Pharma Limited, and space for lot and expiration information.*

FDA Label Image

Cetro-spl-vial-label (Cetro Spl Vial Label)

Label for Cetrorelix Acetate for Injection 0.25 mg per vial, a sterile single-dose vial for subcutaneous use only. The label instructs storage refrigerated at 2-8°C (36-46°F) and protects the vial from light. Manufactured by Gland Pharma Limited, Hyderabad, India, with an NDC of 68083-598.*

FDA Label Image

Cetro-spl-pfs-label (Cetro Spl Pfs Label)

Label for a 1 mL prefilled sterile water for injection, USP vial. The product is manufactured by Gland Pharma Limited in Hyderabad, India. The label includes the NDC 68083-599-01, lot number and expiration date fields, and a barcode for tracking. It is marked as Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.